India, July 31 -- 60 Degrees Pharmaceuticals, Inc. (SXTP), a company focused on developing medicines for vector-borne diseases, announced Thursday that it has entered into definitive agreements for a private placement priced at-the-market under Nasdaq rules.
The offering includes 574,713 shares of common stock (or pre-funded warrants in lieu thereof) Series A warrants to purchase up to 574,713 shares, and short-term Series B warrants to purchase up to 574,713 shares. The purchase price was set $1.74 per share (or per pre-funded warrant), with accompanying warrants issued at an exercise price of $1.49 per share.
The Series A warrants will expire five years from the effective date of the resale registration statement, while the Series B war...